Kimberly (Parker) Cruz MD

Director/ Clinical Research Physician

3402 Kinsman BlvdMadison, WI 53704

Dr. Cruz is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Cruz's full profile Already have an account?

Education & Training

Carilion Clinic-Virginia Tech Carilion School of MedicineResidency, Pediatrics, 2014 - 2017
Ross University School of MedicineClass of 2014

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

FL State Medical License 2017 - 2028
WI State Medical License 2025 - 2027
VA State Medical License 2014 - 2017

Clinical Trials

To Evaluate Efficacy and Safety of Serplulimab + Chemotherapy (Carboplatin- Etoposide) in US Patients With ES-SCLC Start of enrollment: 2022 Nov 18
ACTIVE_NOT_RECRUITING
PHASE3
Dedicated Drug-Drug Interaction (DDI) Study in Healthy Volunteers Start of enrollment: 2021 Oct 15
Completed
Phase 1
A Single-center, Open-label, Study Evaluating Safety and Pharmacokinetics of Single Doses of Zidebactam-Cefepime and Metronidazole Alone or in Combination. Start of enrollment: 2025 Jan 21
COMPLETED
PHASE1

Publications & Presentations

PubMed

20 citations
Potential Application in Mercury Bioremediation of a Marine Sponge-Isolated Bacillus cereus strain Pj1
Juliana F. Santos-Gandelman, Kimberly Cruz, Sharron Crane, Guilherme Muricy, Marcia Giambiagi-deMarval
Current Microbiology. 2014-05-08